7/14/26

Author

Arman Zeytounyan
July 14, 2026

July 7th - July 13th

Here’s your weekly dose

🇺🇸 Most Cannabis Consumers Doubt Federal Rescheduling Will Be Completed This Year, Poll Finds

A new survey of cannabis consumers in state-legal markets found that a majority, 52.5%, do not believe the Trump administration will complete the process of moving all marijuana to Schedule III by the end of 2026, despite ongoing DEA hearings on the proposal. The poll, conducted among more than 1,000 consumers, reflects continued skepticism about the pace of federal cannabis reform even after medical cannabis received partial rescheduling earlier this year. While industry observers note that recent hearing testimony from DEA and FDA officials has been more supportive of rescheduling than many expected, consumers remain divided on whether the process will result in a final decision before year’s end. (Marijuana Moment)

A new study published in Circulation Research found that chronic cannabis use among otherwise healthy young adults was associated with increased inflammatory activity linked to the early development of atherosclerosis, the artery‑narrowing process that can contribute to cardiovascular disease. Researchers observed elevated levels of monocyte migration, foam cell formation and oxidative stress, all considered early indicators of potentially proatherogenic inflammation, with the strongest effects seen among participants who combined cannabis use with nicotine e‑cigarette use. While the findings do not prove that cannabis directly causes heart disease, they add to growing evidence that regular cannabis use may have underappreciated cardiovascular consequences and warrant further long‑term invest. (Ahajournals)

🚫 Cannabis Prohibition Interests Don’t ‘Systemically Align’ With American Public, DOJ Says

The U.S. Department of Justice argued in court filings that organizations seeking to block federal cannabis rescheduling are motivated by financial and institutional interests that do not necessarily align with the broader public goals of the Controlled Substances Act, which focuses on public health, scientific research and legitimate medical access. The DOJ specifically challenged claims from anti-rescheduling groups, including drug-testing and pharmaceutical interests, asserting that their objections are rooted in potential economic impacts rather than the statute’s intended purpose of serving patients, researchers and the general public. The filing represents another notable sign of the federal government’s increasingly supportive stance toward cannabis rescheduling as it continues defending the Schedule III framework against ongoing legal challenges.

👉 Read The Full Study Here

⚠️ Researchers Warn Heavy Marijuana Smoking May Increase Cancer Risk

A new report highlighted by ScienceDaily says growing evidence suggests that heavy marijuana smoking may increase the risk of lung cancer as well as several head and neck cancers, although researchers are still working to determine exactly how much cannabis use is needed before risk rises significantly. Studies cited in the report found that heavy users and people with cannabis use disorder showed elevated rates of both lung cancer and certain head and neck cancers compared with nonusers, adding to a growing body of research on the long-term effects of chronic cannabis smoking. Researchers note that major questions remain about dose-response relationships, while current evidence suggests noncombustible forms such as edibles have not been linked to lung cancer and the long-term impacts of vaping cannabis continue to be investigated. (ScienceDaily)

🗓️ Continued Cannabis News & Events

That’s it for this week.

We love to see you here so keep showing up and if you want to be a part of our community even more you can find us on Instagram @weeklyjoint

P.S. We used to be called Catching up on Cannabis and you were a part of our community between 2018-2021. We’re back with a new name and team!!